In PDAC, known to be an immunologically “cold” tumor, the use of FAP-specific CAR T cells restrained tumor growth as well as reduced vasculature in the tumor through a mechanism that was immune-independent but stromal-dependent [174]. The gene discussed is FAP; the disease is neoplasm.